JFL Life Sciences Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6
JFL Life Sciences has a total shareholder equity of ₹355.8M and total debt of ₹56.9M, which brings its debt-to-equity ratio to 16%. Its total assets and total liabilities are ₹566.4M and ₹210.6M respectively. JFL Life Sciences's EBIT is ₹41.2M making its interest coverage ratio 5. It has cash and short-term investments of ₹300.0K.
Anahtar bilgiler
16.0%
Borç/özkaynak oranı
₹56.90m
Borç
| Faiz karşılama oranı | 5x |
| Nakit | ₹300.00k |
| Eşitlik | ₹355.80m |
| Toplam yükümlülükler | ₹210.60m |
| Toplam varlıklar | ₹566.40m |
Son finansal sağlık güncellemeleri
Güncelleme yok
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: JFLLIFE's short term assets (₹431.3M) exceed its short term liabilities (₹199.8M).
Uzun Vadeli Yükümlülükler: JFLLIFE's short term assets (₹431.3M) exceed its long term liabilities (₹10.8M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: JFLLIFE's net debt to equity ratio (15.9%) is considered satisfactory.
Borcun Azaltılması: JFLLIFE's debt to equity ratio has reduced from 167.6% to 16% over the past 5 years.
Borç Kapsamı: JFLLIFE's debt is well covered by operating cash flow (146.9%).
Faiz Kapsamı: JFLLIFE's interest payments on its debt are well covered by EBIT (5x coverage).